ScopusElsevier Scopus
Status
Active
Coverage
1990–present
Source type
Journal
Open access
No
CiteScore
2.3
SJR · SCImago
0.402
Q3 SJR quartile
H-index
81
Best quartile
Q3 · 42nd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 88 / 151 | 42nd | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Blood Coagulation and Fibrinolysis
Blood Coagulation and Fibrinolysis is Scopus-indexed (Q3, CiteScore 2.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 0957-5235Verify ISSN ↗1473-5733Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Scopus · Q3WoS · SCIEONOS
2.3
CiteScore 2025
Q3
Best quartile
2
Indexed in
Cost to publish: No APC data — check the publisher
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Blood Coagulation and Fibrinolysis indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1990–present, best quartile Q3, CiteScore 2.3.
What quartile is Blood Coagulation and Fibrinolysis in Scopus?
Blood Coagulation and Fibrinolysis is Q3 in Hematology (rank 88 of 151), by CiteScore 2025.
What is the impact factor of Blood Coagulation and Fibrinolysis?
Blood Coagulation and Fibrinolysis is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.3, which places it in quartile Q3 at the 42nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.402, quartile Q3, with an H-index of 81.
Who publishes Blood Coagulation and Fibrinolysis and what is its ISSN?
Blood Coagulation and Fibrinolysis is published by Lippincott Williams and Wilkins. Its print ISSN is 0957-5235 and its online ISSN is 1473-5733.
Is Blood Coagulation and Fibrinolysis covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Blood Coagulation and Fibrinolysis in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Blood Coagulation and Fibrinolysis open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Blood Coagulation and Fibrinolysis? — open metrics via OpenAlex
Blood Coagulation and Fibrinolysis has an h-index of 93 and a 2-year mean of 0.97 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q3. On 2-year citations it ranks #93 of 148 Scopus journals in Hematology.
93
h-index
0.97
2-yr mean citations
2,247
i10-index
5,311
works indexed
81,453
total citations
2-yr mean citations, among Scopus journals in the same subject
#93 of 148 Bottom 38% Hematology
Blood Coagulation and Fibrinolysis published 64 papers in 2025; its busiest recent year was 2020 with 114. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Blood Coagulation and Fibrinolysis? — latest 100 articles, 2025–2026
In its latest 100 research articles (2025–2026), authors are most often from United States (14.5%), China (10.6%) and Türkiye (9.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Blood Coagulation and Fibrinolysis? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 0.4 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Blood Pressure Monitoring Scopus Q2 WoS SCIE Blood Science Scopus Q2 WoS ESCI DOAJ Canadian Journal of Addiction Scopus Q3 WoS ESCI Cancer Journal (United States) Scopus Q2 WoS SCIE Cancer Nursing Scopus Q1 WoS SCIE/SSCI Cardiology in Review Scopus Q2 WoS SCIE Cardiology Plus Scopus Q3 WoS ESCI DOAJ Cardiopulmonary Physical Therapy Journal Scopus Q2
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.